Australia
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours
* Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. * The collaboration includes precli...
2025-11-28 13:00
878
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy
SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxali...
2025-11-19 05:15
1901
Seeing Machines launches world-first 'attention sharing' feature for enhanced distraction detection capability in commercial fleets
CANBERRA, Australia, Nov. 13, 2025 /PRNewswire/ -- Seeing Machines Limited, the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety announces the launch of its enhanced distraction detection feature, known as "attention shari...
2025-11-13 16:00
834
TGE Pursues the Acquisition of the 100th Ritz Carlton Hotel Globally
PARIS, NEW YORK and SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that TGE has entered into ...
2025-11-10 22:25
1880
IR launches new observability-as-a-service platform Prognosis Elevate as hybrid IT complexity surges
Highlights: * Prognosis Elevate is observability-as-a-service for enterprises managing thousands of UC&C endpoints across multiple vendors. * Supports regulated sectors that must balance cloud agility with on-prem and data-residency compliance. * Backed by IR's global 24/7 DevOps and servic...
2025-11-04 10:01
818
TINYBEANS ACQUIRES QEEPSAKE CREATING THE LEADING PRIVACY-FIRST FAMILY MEMORY PLATFORM
Tinybeans accelerates innovation in privacy-first, secure family memory-keeping SYDNEY, Nov. 3, 2025 /PRNewswire/ -- Tinybeans Group (ASX:TNY, OTCQB:TNYYF), the global privacy-first family photo-sharing and journaling app, today announced the acquisition of the assets of Qeepsake Inc., aBoston-ba...
2025-11-04 08:12
1632
Locksley Receives Up to US$191 Million Potential Support from EXIM for U.S. Critical Minerals Push
SAN BERNARDINO, Calif., Nov. 3, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY, OTCQX: LKYRF) announced the receipt of a Letter of Interest (LOI) from the Export-Import Bank ofthe United States (EXIM) outlining the intent to provide up toUS$191 million in potential project financing su...
2025-11-03 21:14
1598
The 2025 Conference on Wang Yangming Mind Philosophy opens in Yuyao, Ningbo
NINGBO, China, Oct. 30, 2025 /PRNewswire/ -- October 31 marks the birth
anniversary of the great Chinese philosopher Wang Yangming (1472-1529). On
October 30, the 2025 Conference on Wang Yangming Mind Philosophy was
inaugurated in Yuyao,Ningbo.
2025-10-31 04:37
1124
e-STORAGE Achieves Commercial Operation of 220 MWh Mannum Battery Energy Storage Project in South Australia
KITCHENER, ON, Oct. 29, 2025 /PRNewswire/ -- Canadian Solar Inc.
2025-10-29 19:00
2163
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics
* Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies * Partnership with T cell experts Daniel J Powell Jr., PhD, and Mark Yarmarkov...
2025-10-28 19:35
691
Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner
SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) p...
2025-10-27 19:15
1670
Clarity signs copper-67 Supply Agreement with Nusano
SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supp...
2025-10-16 21:04
1269
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
* Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses * Phase 1/2 study to enroll ~500 healthy adults, with topline results expected by 2028 * We aim to build a universal Sarbecovirus vaccine platform to proactively address future pandemics SEONGNAM, South Kor...
2025-10-15 20:00
1115
Co-PSMA trial achieves primary endpoint
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT...
2025-10-14 21:03
1191
Locksley Announces Major Advancement at Mojave as Structural Mapping Expands Scale of Antimony Target with a 400% Increase in Target Strike Length
SAN BERNARDINO, Calif., Oct. 10, 2025 /PRNewswire/ -- Locksley Resources, Ltd. (ASX: LKY; OTCQX: LKYRYF) announced that recent structural mapping has significantly expanded the scale of its target mineralized corridor at the Desert Antimony Mine (DAM) Prospect. A new parallel structural target wa...
2025-10-10 20:35
3231
Locksley Reports High-Grade Antimony Concentrate at Significantly Higher Grades than Comparable American Projects in Initial Metallurgical Test Work of Surface Samples from the Company's Desert Antimony Mine Project in California
SAN BERNARDINO, Calif., Oct. 8, 2025 /PRNewswire/ -- Locksley Resources, (ASX: LKY; OTCQB: LKYRF) announced that the company's advancing metallurgical test work program being conducted on surface samples collected from the Desert Antimony Mine (DAM) Prospect at the company's project in the Mojave...
2025-10-08 20:40
2153
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized...
2025-10-07 20:30
1817
FDA Lifts Clinical Hold on NUZ-001
Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...
2025-10-06 14:06
1349
ISX Financial EU Plc Reports Profitable Growth and Strong Capital Position in H1 2025
NICOSIA, Cyprus, Oct. 3, 2025 /PRNewswire/ -- ISX Financial EU Plc (ISXX), a leading provider of regulated transactional banking and real-time payment solutions, today announced its unaudited H1 2025 financial results for the six months ended30 June 2025. ISXX delivered profitable growth, improve...
2025-10-03 21:47
2262
EVOLVE MVMT Launches Wearable to Track Shock Absorption for Runners
Revolutionary running tech offers real-time insights into step quality, injury risk, and performance. BYRON BAY, Australia, Sept. 30, 2025 /PRNewswire/ -- EVOLVE MVMT has launched the world's first wearable designed specifically to measure shock absorption and step quality for runners on Kicksta...
2025-09-30 21:00
1194
Week's Top Stories
Most Reposted
SGTraDex and IMDA Receive Pro-Enterprise Impact & Partnership Award for Interoperable Digital Documents Against Payment Trade Cooperation
[Picked up by 313 media titles]
2025-11-25 15:37
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 311 media titles]
2025-11-27 07:25SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 290 media titles]
2025-11-29 09:00
HOTEL GROOVE SHINJUKU strengthens its services for deaf and hard of hearing guests
[Picked up by 288 media titles]
2025-11-25 10:00
Pop the 90s: The Westin Surabaya and Four Points Pakuwon Indah Welcomes 2026 with a Spectacular Live Show Featuring Project Pop
[Picked up by 284 media titles]
2025-11-26 10:49
Most Read
LightInTheBox to Hold 2025 Annual General Meeting on December 19, 2025
2025-11-25 21:20
2561
STAGWELL (STGW) REVEALS NEW SINGAPORE HUB TO POWER AI-DRIVEN GROWTH AND INNOVATION ACROSS APAC
2025-11-24 13:30
2256
Qudian Inc. Reports Third Quarter 2025 Unaudited Financial Results
2025-11-24 18:00
2127
NYSE Content Advisory: Pre-Market Update + Exzeo Celebrates Recent IPO
2025-11-24 21:56
2117